Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients

Data Availability

All transcriptomics data used for drug predictions can be accessed through public databases indicated in Table 1. The Cerner patient data analyzed in this study is subject to the following licenses/restrictions: This was an observational study of electronic health records that cannot be made publicly available. Requests to access these datasets should be directed to the Cerner Clinical Research Team, coviddatalab{at}cerner.com. All other data generated or analysed during this study are available from the corresponding author on reasonable request.